Search Results - "Pelletier, Ryan"

Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews by Pelletier, Ryan, Ng, Kelvin, Alkabbani, Wajd, Labib, Youssef, Mourad, Nicolas, Gamble, John-Michael

“…Background: Multiple published quantitative systematic reviews have reported on adverse events associated with the use of sodium glucose co-transporter 2…”
Get full text

Protocol for a systematic review and meta-analysis of interventions aimed at delabeling low-risk penicillin allergies with consideration for sex and gender by Maximos, Mira, Elsayed, Sameer, Maxwell, Colleen, Houle, Sherilyn K D, Pelletier, Ryan, McConnell, Brie, Pylypiak, Andrew, Gamble, John-Michael

“…Approximately, 10% of people report a penicillin allergy; however, more than 90% can safely undergo delabeling after a detailed history, oral challenge, or…”
Get full text

The association of sodium‐glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews by Pelletier, Ryan, Ng, Kelvin, Alkabbani, Wajd, Labib, Youssef, Mourad, Nicolas, Gamble, John‐Michael

“…Aims To summarize reported cancer events associated with SGLT‐2 inhibitors used in patients with type 2 diabetes mellitus, as well as assess the quality of…”
Get full text

Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre by Pelletier, Ryan

“…Objectives The objectives of this paper were to identify and compare clinical prediction models used to assess the risk of venous thromboembolism (VTE) in…”
Get full text

Variation in bleeding risk estimates among online calculators by Pelletier, Ryan, Nagge, Jeff, Gamble, John-Michael

“…Objective To assess the variation in bleeding risk estimates and risk stratification among Web and mobile applications for patients with atrial fibrillation…”
Get full text

Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events by Alkabbani, Wajd, Pelletier, Ryan, Gamble, John-Michael

“…Evidence from observational studies may be considered complementary to that of randomized controlled trials (RCTs), particularly when assessing rare outcomes…”
Get full text

Variation in bleeding risk estimates among online calculators: Cross-sectional study of apps used by and for patients with atrial fibrillation by Pelletier, Ryan, Nagge, Jeff, Gamble, John-Michael

“…To assess the variation in bleeding risk estimates and risk stratification among Web and mobile applications for patients with atrial fibrillation…”
Get full text

Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data by Alkabbani, Wajd, Pelletier, Ryan, Beazely, Michael A., Labib, Youssef, Quan, Breanna, Gamble, John-Michael

“…Introduction An increased risk of myopathy due to a potential interaction between sodium glucose co-transporter-2 inhibitors (SGLT-2i) and HMG-CoA reductase…”
Get full text

Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors and The Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events by Alkabbani, Wajd, Pelletier, Ryan, Gamble, John-Michael

“…Evidence from observational studies may be considered complementary to that of randomized controlled trials (RCTs), particularly when assessing rare outcomes…”
Get full text

WHAT ARE THE TOP THREE TECHNOLOGY PURCHASES YOU HAVE ON YOUR SHOPPING LIST FOR WORK? by Pelletier, Ryan, Pavlicek, Cara, Hoffman, Seth

“…Three public officicals share what are the top three technology purchases they have on their shopping list for work. The public officicals include County…”
Get full text